Skip to main content

Table 3 ROC analyses for meaningful risk factors

From: Assessment of androgen receptor expression in breast cancer patients using 18 F-FDG PET/CT radiomics and clinicopathological characteristics

Features

AUC

(95% CI)

cutoff

p

Se (%)

Sp (%)

SHAPE_SphericityCT

0.747

(0.601–0.862)

> 0.6152

0.0010*

39.39

100.00

GLCM_ContrastCT

0.673

(0.522–0.801)

> 7.3826

0.0346*

78.79

60.00

NGLDM_CoarsenessCT

0.691

(0.541–0.816)

> 0.0020

0.0113*

45.45

100.00

SHAPE_SphericityPET

0.739

(0.593–0.855)

> 0.7362

0.0017*

51.52

86.67

NGLDM_CoarsenessPET

0.653

(0.501–0.784)

> 0.0431

0.0587

39.39

100.00

MTV

0.695

(0.545–0.820)

≤ 13.1048

0.0096*

45.45

100.00

  1. ROC, receiver operating characteristic; AUC, the area under the curve; Se, Sensitivity; Sp, Specificity. *p < 0.05